NMU's Compliance Database - Northern Michigan University
Controlled Substances Act
| Reviewed By | Internal Auditor Owner |
| Regulation Reference Cite | 21 U.S.C. §§ 801-889: 21 C.F.R. § 1300 |
| Report Due Date (Actual) | 01/15/2018 |
| Level | Compliance Report |
| Oversight Unit | HEALTH CENTER |
| Person Responsible | Robin Aho |
| Secondary Person Responsible | Janice Nolan |
| President / VP Level | Finance |
| Description |
By January 15, qualifying entities must submit to the Attorney General an annual report of controlled substances in stock and quarterly reports of acquisition and distribution of controlled substances. Regulates the manufacture and distribution of narcotics, stimulants, depressants, hallucinogens, anabolic steroids, and chemicals used in the illicit production of controlled substances. All substances are placed in one of five schedules, based on medicinal value, harmfulness, and potential for abuse or addiction, with Schedule 1 reserved for the most dangerous drugs that have no recognized medical use. |
| Contacts and Data Sources |
| Robin Aho |
| Internal Notes |
| This compliance item has notes that are available internally to the oversight unit. Please contact the Risk Management Department for more information |